EWTX logo

Edgewise Therapeutics (EWTX) Total liabilities

annual total liabilities:

$27.60M+$6.40M(+30.16%)
December 31, 2024

Summary

  • As of today (July 6, 2025), EWTX annual total liabilities is $27.60 million, with the most recent change of +$6.40 million (+30.16%) on December 31, 2024.
  • During the last 3 years, EWTX annual total liabilities has risen by +$16.75 million (+154.39%).
  • EWTX annual total liabilities is now -83.23% below its all-time high of $164.56 million, reached on December 31, 2020.

Performance

EWTX Total liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWTXbalance sheet metrics

quarterly total liabilities:

$24.67M-$2.93M(-10.61%)
March 31, 2025

Summary

  • As of today (July 6, 2025), EWTX quarterly total liabilities is $24.67 million, with the most recent change of -$2.93 million (-10.61%) on March 31, 2025.
  • Over the past year, EWTX quarterly total liabilities has increased by +$5.81 million (+30.78%).
  • EWTX quarterly total liabilities is now -85.01% below its all-time high of $164.56 million, reached on December 31, 2020.

Performance

EWTX quarterly total liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWTXbalance sheet metrics

Total liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

EWTX Total liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+30.2%+30.8%
3 y3 years+154.4%+99.1%
5 y5 years-33.3%-

EWTX Total liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+154.4%-10.6%+123.4%
5 y5-year-83.2%+154.4%-85.0%+408.6%
alltimeall time-83.2%+154.4%-85.0%+408.6%

EWTX Total liabilities History

DateAnnualQuarterly
Mar 2025
-
$24.67M(-10.6%)
Dec 2024
$27.60M(+30.2%)
$27.60M(+23.2%)
Sep 2024
-
$22.41M(+5.8%)
Jun 2024
-
$21.17M(+12.2%)
Mar 2024
-
$18.86M(-11.0%)
Dec 2023
$21.20M(+4.0%)
$21.20M(+1.3%)
Sep 2023
-
$20.94M(+9.2%)
Jun 2023
-
$19.17M(+9.2%)
Mar 2023
-
$17.56M(-13.9%)
DateAnnualQuarterly
Dec 2022
$20.39M(+87.9%)
$20.39M(+29.4%)
Sep 2022
-
$15.75M(+42.6%)
Jun 2022
-
$11.04M(-10.9%)
Mar 2022
-
$12.39M(+14.2%)
Dec 2021
$10.85M(-93.4%)
$10.85M(+19.9%)
Sep 2021
-
$9.05M(+34.3%)
Jun 2021
-
$6.74M(+38.9%)
Mar 2021
-
$4.85M(-97.1%)
Dec 2020
$164.56M(+297.5%)
$164.56M
Dec 2019
$41.39M
-

FAQ

  • What is Edgewise Therapeutics annual total liabilities?
  • What is the all time high annual total liabilities for Edgewise Therapeutics?
  • What is Edgewise Therapeutics annual total liabilities year-on-year change?
  • What is Edgewise Therapeutics quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Edgewise Therapeutics?
  • What is Edgewise Therapeutics quarterly total liabilities year-on-year change?

What is Edgewise Therapeutics annual total liabilities?

The current annual total liabilities of EWTX is $27.60M

What is the all time high annual total liabilities for Edgewise Therapeutics?

Edgewise Therapeutics all-time high annual total liabilities is $164.56M

What is Edgewise Therapeutics annual total liabilities year-on-year change?

Over the past year, EWTX annual total liabilities has changed by +$6.40M (+30.16%)

What is Edgewise Therapeutics quarterly total liabilities?

The current quarterly total liabilities of EWTX is $24.67M

What is the all time high quarterly total liabilities for Edgewise Therapeutics?

Edgewise Therapeutics all-time high quarterly total liabilities is $164.56M

What is Edgewise Therapeutics quarterly total liabilities year-on-year change?

Over the past year, EWTX quarterly total liabilities has changed by +$5.81M (+30.78%)
On this page